-
1
-
-
0037057683
-
Helicobacter pylori infection
-
Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002; 347: 1175-1186
-
(2002)
N Engl J Med
, vol.347
, pp. 1175-1186
-
-
Suerbaum, S.1
Michetti, P.2
-
2
-
-
35848963397
-
Meta-analysis: Duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication
-
Fuccio L, Minardi ME, Zagari RM, Grilli D, Magrini N, Bazzoli F. Meta-analysis: duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication. Ann Intern Med 2007; 147: 553-562
-
(2007)
Ann Intern Med
, vol.147
, pp. 553-562
-
-
Fuccio, L.1
Minardi, M.E.2
Zagari, R.M.3
Grilli, D.4
Magrini, N.5
Bazzoli, F.6
-
3
-
-
0007429598
-
Guidelines for the management of Helicobacter pylori infection. Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology
-
Howden CW, Hunt RH. Guidelines for the management of Helicobacter pylori infection. Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology. Am J Gastroenterol 1998; 93: 2330-2338
-
(1998)
Am J Gastroenterol
, vol.93
, pp. 2330-2338
-
-
Howden, C.W.1
Hunt, R.H.2
-
4
-
-
0036171551
-
Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report
-
Malfertheiner P, Mégraud F, O'Morain C, Hungin AP, Jones R, Axon A, Graham DY, Tytgat G. Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 2002; 16: 167-180
-
(2002)
Aliment Pharmacol Ther
, vol.16
, pp. 167-180
-
-
Malfertheiner, P.1
Mégraud, F.2
O'Morain, C.3
Hungin, A.P.4
Jones, R.5
Axon, A.6
Graham, D.Y.7
Tytgat, G.8
-
5
-
-
34247844165
-
Current concepts in the management of Helicobacter pylori infection: The Maastricht III Consensus Report
-
Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El- Omar E, Graham D, Hunt R, Rokkas T, Vakil N, Kuipers EJ. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007; 56: 772-781
-
(2007)
Gut
, vol.56
, pp. 772-781
-
-
Malfertheiner, P.1
Megraud, F.2
O'Morain, C.3
Bazzoli, F.4
El-Omar, E.5
Graham, D.6
Hunt, R.7
Rokkas, T.8
Vakil, N.9
Kuipers, E.J.10
-
6
-
-
0033788930
-
Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: A meta-analysis of eradication of Helicobacter pylori
-
Gisbert JP, González L, Calvet X, García N, López T, Roqué M, Gabriel R, Pajares JM. Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori. Aliment Pharmacol Ther 2000; 14: 1319-1328
-
(2000)
Aliment Pharmacol Ther
, vol.14
, pp. 1319-1328
-
-
Gisbert, J.P.1
González, L.2
Calvet, X.3
García, N.4
López, T.5
Roqué, M.6
Gabriel, R.7
Pajares, J.M.8
-
7
-
-
35948981603
-
Evolution of Helicobacter pylori therapy from a meta-analytical perspective
-
Gisbert JP, Pajares R, Pajares JM. Evolution of Helicobacter pylori therapy from a meta-analytical perspective. Helicobacter 2007; 12 Suppl 2: 50-58
-
(2007)
Helicobacter
, vol.12
, Issue.SUPPL. 2
, pp. 50-58
-
-
Gisbert, J.P.1
Pajares, R.2
Pajares, J.M.3
-
8
-
-
64849083887
-
Rescue regimens after Helicobacter pylori treatment failure
-
Gisbert JP. Rescue regimens after Helicobacter pylori treatment failure. World J Gastroenterol 2008; 14: 5385-5402
-
(2008)
World J Gastroenterol
, vol.14
, pp. 5385-5402
-
-
Gisbert, J.P.1
-
9
-
-
0032838090
-
A systematic review of Helicobacter pylori eradication therapy--the impact of antimicrobial resistance on eradication rates
-
Houben MH, van de Beek D, Hensen EF, Craen AJ, Rauws EA, Tytgat GN. A systematic review of Helicobacter pylori eradication therapy--the impact of antimicrobial resistance on eradication rates. Aliment Pharmacol Ther 1999; 13: 1047-1055
-
(1999)
Aliment Pharmacol Ther
, vol.13
, pp. 1047-1055
-
-
Houben, M.H.1
van de Beek, D.2
Hensen, E.F.3
Craen, A.J.4
Rauws, E.A.5
Tytgat, G.N.6
-
10
-
-
0032965686
-
A practical approach to patients with refractory Helicobacter pylori infection, or who are re-infected after standard therapy
-
Peitz U, Hackelsberger A, Malfertheiner P. A practical approach to patients with refractory Helicobacter pylori infection, or who are re-infected after standard therapy. Drugs 1999; 57: 905-920
-
(1999)
Drugs
, vol.57
, pp. 905-920
-
-
Peitz, U.1
Hackelsberger, A.2
Malfertheiner, P.3
-
11
-
-
0034003268
-
Effect of pretreatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy: A meta-analytical approach
-
Dore MP, Leandro G, Realdi G, Sepulveda AR, Graham DY. Effect of pretreatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy: a meta-analytical approach. Dig Dis Sci 2000; 45: 68-76
-
(2000)
Dig Dis Sci
, vol.45
, pp. 68-76
-
-
Dore, M.P.1
Leandro, G.2
Realdi, G.3
Sepulveda, A.R.4
Graham, D.Y.5
-
12
-
-
0033015306
-
The influence of in vitro nitroimidazole resistance on the efficacy of nitroimidazole-containing anti-Helicobacter pylori regimens: A meta-analysis
-
van der Wouden EJ, Thijs JC, van Zwet AA, Sluiter WJ, Kleibeuker JH. The influence of in vitro nitroimidazole resistance on the efficacy of nitroimidazole-containing anti-Helicobacter pylori regimens: a meta-analysis. Am J Gastroenterol 1999; 94: 1751-1759
-
(1999)
Am J Gastroenterol
, vol.94
, pp. 1751-1759
-
-
van der Wouden, E.J.1
Thijs, J.C.2
van Zwet, A.A.3
Sluiter, W.J.4
Kleibeuker, J.H.5
-
13
-
-
0031310378
-
Failed treatment of Helicobacter pylori infection associated with resistance to clarithromycin
-
Tompkins DS, Perkin J, Smith C. Failed treatment of Helicobacter pylori infection associated with resistance to clarithromycin. Helicobacter 1997; 2: 185-187
-
(1997)
Helicobacter
, vol.2
, pp. 185-187
-
-
Tompkins, D.S.1
Perkin, J.2
Smith, C.3
-
14
-
-
0032173042
-
Clarithromycin-resistant Helicobacter pylori in patients with duodenal ulcer in the United States
-
Vakil N, Hahn B, McSorley D. Clarithromycin-resistant Helicobacter pylori in patients with duodenal ulcer in the United States. Am J Gastroenterol 1998; 93: 1432-1435
-
(1998)
Am J Gastroenterol
, vol.93
, pp. 1432-1435
-
-
Vakil, N.1
Hahn, B.2
McSorley, D.3
-
15
-
-
4344592305
-
H pylori antibiotic resistance: Prevalence, importance, and advances in testing
-
Mégraud F. H pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut 2004; 53: 1374-1384
-
(2004)
Gut
, vol.53
, pp. 1374-1384
-
-
Mégraud, F.1
-
16
-
-
0038368758
-
Safety and efficacy of 7-day rabeprazole- and omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with documented peptic ulcer disease
-
Hawkey CJ, Atherton JC, Treichel HC, Thjodleifsson B, Ravic M. Safety and efficacy of 7-day rabeprazole- and omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with documented peptic ulcer disease. Aliment Pharmacol Ther 2003; 17: 1065-1074
-
(2003)
Aliment Pharmacol Ther
, vol.17
, pp. 1065-1074
-
-
Hawkey, C.J.1
Atherton, J.C.2
Treichel, H.C.3
Thjodleifsson, B.4
Ravic, M.5
-
17
-
-
33750545145
-
Pica R. 2-week triple therapy for Helicobacter pylori infection is better than 1-week in clinical practice: A large prospective single-center randomized study
-
Paoluzi P, Iacopini F, Crispino P, Nardi F, Bella A, Rivera M, Rossi P, Gurnari M, Caracciolo F, Zippi M, Pica R. 2-week triple therapy for Helicobacter pylori infection is better than 1-week in clinical practice: a large prospective single-center randomized study. Helicobacter 2006; 11: 562-568
-
(2006)
Helicobacter
, vol.11
, pp. 562-568
-
-
Paoluzi, P.1
Iacopini, F.2
Crispino, P.3
Nardi, F.4
Bella, A.5
Rivera, M.6
Rossi, P.7
Gurnari, M.8
Caracciolo, F.9
Zippi, M.10
-
18
-
-
0038772377
-
One-week triple therapy with esomeprazole, clarithromycin and metronidazole provides effective eradication of Helicobacter pylori infection
-
Veldhuyzen Van Zanten S, Machado S, Lee J. One-week triple therapy with esomeprazole, clarithromycin and metronidazole provides effective eradication of Helicobacter pylori infection. Aliment Pharmacol Ther 2003; 17: 1381-1387
-
(2003)
Aliment Pharmacol Ther
, vol.17
, pp. 1381-1387
-
-
van Zanten, V.S.1
Machado, S.2
Lee, J.3
-
20
-
-
0033634852
-
Esomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: Results of three US multicenter, double-blind trials
-
Laine L, Fennerty MB, Osato M, Sugg J, Suchower L, Probst P, Levine JG. Esomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: results of three US multicenter, double-blind trials. Am J Gastroenterol 2000; 95: 3393-3398
-
(2000)
Am J Gastroenterol
, vol.95
, pp. 3393-3398
-
-
Laine, L.1
Fennerty, M.B.2
Osato, M.3
Sugg, J.4
Suchower, L.5
Probst, P.6
Levine, J.G.7
-
21
-
-
0032460579
-
Twicedaily, 10-day triple therapy with omeprazole, amoxicillin, and clarithromycin for Helicobacter pylori eradication in duodenal ulcer disease: Results of three multicenter, doubleblind, United States trials
-
Laine L, Suchower L, Frantz J, Connors A, Neil G. Twicedaily, 10-day triple therapy with omeprazole, amoxicillin, and clarithromycin for Helicobacter pylori eradication in duodenal ulcer disease: results of three multicenter, doubleblind, United States trials. Am J Gastroenterol 1998; 93: 2106-2112
-
(1998)
Am J Gastroenterol
, vol.93
, pp. 2106-2112
-
-
Laine, L.1
Suchower, L.2
Frantz, J.3
Connors, A.4
Neil, G.5
-
22
-
-
25644458593
-
Seven versus ten days of rabeprazole triple therapy for Helicobacter pylori eradication: A multicenter randomized trial
-
Calvet X, Ducons J, Bujanda L, Bory F, Montserrat A, Gisbert JP. Seven versus ten days of rabeprazole triple therapy for Helicobacter pylori eradication: a multicenter randomized trial. Am J Gastroenterol 2005; 100: 1696-1701
-
(2005)
Am J Gastroenterol
, vol.100
, pp. 1696-1701
-
-
Calvet, X.1
Ducons, J.2
Bujanda, L.3
Bory, F.4
Montserrat, A.5
Gisbert, J.P.6
-
23
-
-
27744585345
-
Esomeprazole-based therapy in Helicobacter pylori eradication: Any effect by increasing the dose of esomeprazole or prolonging the treatment?
-
Gisbert JP, Domínguez-Muñoz A, Domínguez-Martín A, Gisbert JL, Marcos S. Esomeprazole-based therapy in Helicobacter pylori eradication: any effect by increasing the dose of esomeprazole or prolonging the treatment? Am J Gastroenterol 2005; 100: 1935-1940
-
(2005)
Am J Gastroenterol
, vol.100
, pp. 1935-1940
-
-
Gisbert, J.P.1
Domínguez-Muñoz, A.2
Domínguez-Martín, A.3
Gisbert, J.L.4
Marcos, S.5
-
24
-
-
0036024201
-
Effectiveness of Helicobacter pylori eradication treatments in a primary care setting in Italy
-
Della Monica P, Lavagna A, Masoero G, Lombardo L, Crocellá L, Pera A. Effectiveness of Helicobacter pylori eradication treatments in a primary care setting in Italy. Aliment Pharmacol Ther 2002; 16: 1269-1275
-
(2002)
Aliment Pharmacol Ther
, vol.16
, pp. 1269-1275
-
-
della Monica, P.1
Lavagna, A.2
Masoero, G.3
Lombardo, L.4
Crocellá, L.5
Pera, A.6
-
25
-
-
31144447912
-
Effect of Clostridium butyricum on fecal flora in Helicobacter pylori eradication therapy
-
Shimbo I, Yamaguchi T, Odaka T, Nakajima K, Koide A, Koyama H, Saisho H. Effect of Clostridium butyricum on fecal flora in Helicobacter pylori eradication therapy. World J Gastroenterol 2005; 11: 7520-7524
-
(2005)
World J Gastroenterol
, vol.11
, pp. 7520-7524
-
-
Shimbo, I.1
Yamaguchi, T.2
Odaka, T.3
Nakajima, K.4
Koide, A.5
Koyama, H.6
Saisho, H.7
-
26
-
-
10644271521
-
Aging and upper gastrointestinal disorders
-
Pilotto A. Aging and upper gastrointestinal disorders. Best Pract Res Clin Gastroenterol 2004; 18 Suppl: 73-81
-
(2004)
Best Pract Res Clin Gastroenterol
, vol.18
, Issue.SUPPL.
, pp. 73-81
-
-
Pilotto, A.1
|